Who is sponsoring NCT05244265?

NCT05244265 is sponsored by Karolinska Institutet.

What drugs are being tested in NCT05244265?

Interventions in NCT05244265: Mindfulness-based stress reduction (MBSR), Treatment as usual (TAU).

What condition does NCT05244265 study?

NCT05244265 studies Treatment Satisfaction, Participation Rate, Patient, Quality of Life, Mental Illness, Acceptance Processes, Stress, Psychological.

Is NCT05244265 still recruiting?

NCT05244265 is currently terminated. Last updated 8 March 2022.

Last reviewed 2022-03-08 · How we verify

NCT05244265

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Mindfulness Based Stress Reduction for Intellectually Able Autistic Adults

Terminated NA Last updated 8 March 2022

What this trial tests

NA trial testing Mindfulness-based stress reduction (MBSR) in Treatment Satisfaction in 140 participants. Terminated before completion.

Timeline

1 January 2016

Primary endpoint
1 September 2021

1 September 2021

Quick facts

Lead sponsor	Karolinska Institutet
Phase	NA
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	quadruple
Primary purpose	treatment
Enrollment	140
Start date	1 January 2016
Primary completion	1 September 2021
Estimated completion	1 September 2021

Drugs / interventions tested

Mindfulness-based stress reduction (MBSR)
Treatment as usual (TAU) — full drug profile →

Conditions studied

Treatment Satisfaction — all drugs for Treatment Satisfaction →
Participation Rate, Patient — all drugs for Participation Rate, Patient →
Quality of Life — all drugs for Quality of Life →
Mental Illness — all drugs for Mental Illness →

Sponsor

Karolinska Institutet

Who can join

18 and older, any sex, with Treatment Satisfaction or Participation Rate, Patient. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This project evaluates mindfulness based stress-reduction (MBSR), adjusted and manualized for intellectually able autistic adults. MBSR is a skills training program based on further development of cognitive behavioral therapy. The program includes eight weekly group training sessions and one full-day retreat, aiming at stress reduction and improved coping in everyday life, as well as improved mental health. The aspiration is to make ASD-adjusted MBSR an intervention that is acceptable and accessible to individuals with autism in open clinical care. This includes considering variability in background factors such as age, comorbidity and other personal qualities and preferences. The aim of the studies is to evaluate (1) the feasibility and (2) effectiveness of MBSR in adults (18 or over) with autism without intellectual disability, in an outpatient clinical habilitation context.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Mindfulness-based stress reduction for autistic adults: A feasibility study in an outpatient context.
Agius H, Luoto AK, Backman A, Eriksdotter C, et al · · 2024 · cited 5× · PMID 37190953 · DOI 10.1177/13623613231172809

Verify or expand the search:

Other trials of Mindfulness-based stress reduction (MBSR)

Trials testing the same drug.

NCT05843409 — Mindfulness-based Stress Reduction (MBSR) for Reduction of Chronic Pain and Drug Therapie · NA · unknown
NCT07180784 — Psychological Interventions for Students With Insomnia · NA · completed
NCT04100239 — A Pilot and Feasibility Trial of a Group Mindfulness and Self-compassion Intervention for Young People Diagnosed With IB · NA · unknown
NCT05451758 — The Effectiveness of MBSR in Natural Environments · NA · completed
NCT02136485 — Mindfulness-based Stress Reduction in Multiple Sclerosis · NA · completed

Other Karolinska Institutet trials

Trials by the same sponsor.

NCT06359262 — Evaluating the Hope@School Prevention Program · NA · not yet recruiting
NCT07289490 — Bilateral vs Unilateral Inguinal Hernia Repairs With an Asymptomatic Inguinal Hernia in Bilateral Hernias · NA · not yet recruiting
NCT06894264 — Emotion Processing and Regulation in People With Intellectual Disability · NA · not yet recruiting
NCT07494266 — Safety of a Healthy Plant-based Diet With Higher Potassium Content, Compared to a Healthy Plant-based Diet With Limited · NA · not yet recruiting
NCT07442032 — Cardiovascular Phenotypes in Sepsis · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05244265 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Karolinska Institutet
Last refreshed: 8 March 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05244265.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing